Forcing TRIPS on poorest countries threatens generics firms
This article was originally published in Scrip
Executive Summary
Generics companies are likely to suffer if a plea from the world's poorest countries to be exempt from tough international intellectual property rights protection rules is ignored, warns Médecins Sans Frontières.